@article{53f5d29701024f7b9a2040ddf82d7426,
title = "Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee",
keywords = "ACC Concise Clinical Guidance, agammaglobulinemia tyrosine kinase, angiogenesis inhibitors, cancer survivors, cardiac toxicity, CV toxicity, immune checkpoint inhibitors",
author = "Sarju Ganatra and Ana Barac and Saro Armenian and Christine Cambareri and Denlinger, \{Crystal S.\} and Dent, \{Susan F.\} and Salim Hayek and Bonnie Ky and Monika Leja and Lucas, \{Claire Huang\} and Bhargav Makwana and Palaskas, \{Nicolas L.\} and Vo, \{Jacqueline B.\}",
year = "2026",
month = feb,
day = "10",
doi = "10.1016/j.jacc.2025.10.018",
language = "English (US)",
volume = "87",
pages = "654--682",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "5",
}